# Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1

> **NCT04718623** · — · UNKNOWN · sponsor: **Alexandria University** · enrollment: 30 (estimated)

## Conditions studied

- Sepsis Following A Procedure
- Diagnoses, Syndromes, and Conditions

## Interventions

- **DIAGNOSTIC_TEST:** Quantitative determination of serum Presepsin (sCD-14), and Syndecan-1 concentrations

## Key facts

- **NCT ID:** NCT04718623
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02
- **Primary completion:** 2022-03
- **Final completion:** 2022-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718623, "Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04718623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*